Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3526701014 | Ibandronate sodium monohydrate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3526702019 | Ibandronate sodium monohydrate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 817001000172112 | ibandronate sodique monohydraté | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 817011000172110 | ibandroninenatriummonohydraat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ibandronate sodium monohydrate | Is a | Ibandronate sodium (substance) | false | Inferred relationship | Some | ||
| Ibandronate sodium monohydrate | Is modification of (attribute) | Ibandronate sodium (substance) | true | Inferred relationship | Some | ||
| Ibandronate sodium monohydrate | Is a | Ibandronate | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | False | Ibandronate sodium monohydrate | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR